SEMHF:OTC-Siemens Healthineers AG (USD)

COMMON STOCK | | OTC

Last Closing Price

USD 55.75

Change

+1.25 (+2.29)%

Market Cap

USD 53.84B

Volume

500.00

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. The Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions and informatics products. The Advanced Therapies segment offers integrated products, solutions, and services for therapy departments of healthcare providers; and robotic-assisted platform for endo-vascular coronary and peripheral vascular interventions. This segment's principal products include angiography systems and mobile C-arms. It also provides customer value chain services, including design, maintenance, operational management, training, and education services. In addition, the company offers equipment performance management, clinical education and e-learning, asset management, and managed departmental services, as well as digital health products and services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-16 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DFIFF Diamond Fields Resources Inc

-0.01 (-4.00%)

USD174.34B 39.43 N/A
BTHI Big Time Holdings, Inc

N/A

USD151.65B N/A N/A
WXIBF WuXi Biologics (Cayman) Inc

N/A

USD55.21B 226.15 27.12
YACAF Yancoal Australia Ltd

-0.01 (-0.57%)

USD52.26B 0.20 N/A
HENOF Henkel AG & Co. KGaA

+1.97 (+1.70%)

USD47.74B 29.99 15.99
MQBKY Macquarie Group Limited

-1.13 (-0.92%)

USD44.23B 25.89 9.16
SZHIF Shenzhou International Group H..

N/A

USD36.08B 42.39 N/A
SUVPF Sartorius Aktiengesellschaft

N/A

USD35.39B 134.01 N/A
PETFF PTT Public Company Limited

N/A

USD35.38B 32.14 0.20
SARTF Sartorius Aktiengesellschaft

N/A

USD35.36B 112.11 N/A

ETFs Containing SEMHF

Symbol Name Weight Mer Price(Change) Market Cap
FPXE First Trust IPOX Europe E.. 0.00 % 0.70 %

+0.22 (+0.75%)

USD5.78M
C007:XETRA Lyxor MDAX (DR) UCITS ETF 0.00 % 0.30 %

+0.22 (+0.72%)

USD0.23B
IQQM:XETRA iShares EURO STOXX Mid UC.. 0.00 % 0.40 %

+0.51 (+0.75%)

USD0.44B
F751:XETRA ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B
EXSD:XETRA iShares STOXX Europe Mid .. 0.00 % 0.20 %

+0.53 (+0.97%)

USD0.52B
EXS3:XETRA iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

+2.15 (+0.77%)

USD5,933.92B
EXS2:XETRA iShares TecDAX UCITS ETF .. 0.00 % 0.51 %

+0.07 (+0.20%)

USD5,933.97B
ELF1:XETRA Deka MDAX UCITS ETF 0.00 % 0.00 %

+2.40 (+0.76%)

USD0.69B
E908:XETRA Lyxor 1 TecDAX UCITS ETF 0.00 % 0.40 %

+0.03 (+0.11%)

USD0.09B
E907:XETRA Lyxor 1 MDAX UCITS ETF 0.00 % 0.30 %

+1.24 (+0.71%)

USD0.21B
XDGM:F Xtrackers Germany Mittels.. 0.00 % 0.40 %

+0.13 (+0.42%)

USD0.07B
XDGM:LSE Xtrackers (IE) Plc - Xtra.. 0.00 % 0.40 %

+0.17 (+0.56%)

USD0.10B
IQQM:F iShares EURO STOXX Mid UC.. 0.00 % 0.40 %

+0.62 (+0.91%)

USD0.44B
F751:F ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B
EXS3:F iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

+1.70 (+0.61%)

USD5,933.92B
EXS2:F iShares TecDAX UCITS ETF .. 0.00 % 0.51 %

+0.06 (+0.19%)

USD5,933.97B
ELF1:F Deka MDAX UCITS ETF 0.00 % 0.00 %

+2.50 (+0.79%)

USD0.56B
E908:F Lyxor 1 TecDAX UCITS ETF 0.00 % 0.40 %

+0.03 (+0.09%)

USD0.08B
E907:F Lyxor 1 MDAX UCITS ETF 0.00 % 0.30 %

+1.24 (+0.71%)

USD0.11B
C007:F ComStage MDAX UCITS ETF 0.00 % 0.30 %

+0.21 (+0.69%)

USD0.19B
XDGM:XETRA Xtrackers (IE) Plc - Xtra.. 0.00 % 0.40 %

+0.17 (+0.56%)

USD0.10B

Market Performance

  Market Performance vs.
Industry/Classification ()
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.89% N/A N/A 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.89% N/A N/A 40% F
Trailing 12 Months  
Capital Gain 38.25% N/A N/A 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.25% N/A N/A 40% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.80% N/A N/A 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.80% N/A N/A 44% F
Risk Return Profile  
Volatility (Standard Deviation) 11.85% N/A N/A 91% A-
Risk Adjusted Return 48.97% N/A N/A 79% C+
Market Capitalization 53.84B N/A N/A 98% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
()
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.36 N/A N/A 27% F
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 27.93 N/A N/A 8% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 14.12% N/A N/A 83% B
Return on Invested Capital -7.46% N/A N/A 27% F
Return on Assets 5.77% N/A N/A 87% B+
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.46 N/A N/A 69% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike